drugset / Trial / NCT07047209
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is being conducted to learn about safety and tolerability of digoxin in ALS individuals. Additionally, this trial aims to better understand if digoxin has an effect on slowing neurodegeneration in ALS.
Timeline
- Start
- 2025-05-27
- Primary completion
- 2026-03
- Completion
- 2026-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 62.5 ug | Oral |
| Subject | Digoxin | Other / unclassified | 125 ug | Oral |
| Subject | Digoxin | Other / unclassified | 250 ug | Oral |